Microbiology testing is used for
individuals in order to detect the presence of pathogenic microorganisms
and their metabolites. It is growing at a faster pace due to rise in
the demand from in-vitro diagnostics industry and for its application to
check for impurity or presence of any microorganisms such as yeast,
fungi, bacteria, and viruses in a sample. For example, microbiology
testing is beneficial for examining the microbial presence in a given
sample, for the diagnosis of tuberculosis, syphilis, Ebola virus, HIV
and many infectious diseases. It is used in various applications such as
healthcare for disease diagnostics, in the food industry for food
safety testing especially the canned foods, in the cosmetic industry,
and for environmental monitoring. The Food and Drug Administration (FDA)
has set scientific standards for microbiology testing in various
applications. The companies that manufacture drugs, cosmetics, packaged
food items, etc., use these regulatory standards to ensure that their
products are safe for human consumption.
Global microbiology testing market can be
segmented on the basis of product (consumable and instruments), by
microbial testing type (viral, bacterial, and fungal), by applications
(traditional, rapid, and molecular) and by end-user (hospitals and
academics), and by geography. On the basis of products, the segments are
consumables and instruments. Consumables are further divided into
reagents and kits. Kits occupy the major market share amongst
consumables due to its rise in utility by healthcare and diagnostic
centers. Instruments are subdivided into microbiology analyzers,
automated microbiology instruments, and microbiology analyzers. It is
projected that automated microbiology instruments will experience a
rapid growth in the upcoming years. Microbiology analyzers are segmented
into microscopes, molecular diagnostic instruments, and mass
spectrometers. Mass spectrometers are expected to experience a swift
development due to increase in the adoption of the device as well as
increasing efficiency. Based on the testing type the microbiology
testing can be done for the analysis of bacteria like E. coli, fungi
(e.g. mold), and viruses such as HIV and Ebola. It can also be used to
detect the presence of endotoxins, mycotoxins, pollen, allergens, and
particulates in the air, water, dust, food, and consumer products. On
the basis of end-user, the microbiology testing market is segmented into
academia and hospitals. Academia includes research laboratories,
microbial testing labs, food testing laboratory and pathology labs,
while in hospitals microbial testing is used for the diagnosis of
respiratory diseases, periodontal diseases, sexually transmitted
infections, and urinary tract infections. Respiratory disease segment
dominates the market owing to rise in inflammatory diseases as a result
of rising population of smokers and increase in pollution level which
may lead to certain chronic diseases such as asthma.
Technological developments, growing
awareness about preventive medicine, rising incidence of infectious
diseases, favorable funding and research grants, growing healthcare
expenditure across the world, and public-private investments in the
field of life science research & developments are the key market
drivers for the microbiology testing industry. Furthermore, improving
healthcare infrastructure across the emerging markets demand for
advanced molecular diagnostic products. Operational barriers to
diagnostic test usage, intense competition among vendors, and bundled
sales by market leaders across major markets are the major challenge
limiting the growth of the microbiology testing market. However, growing
demand for point-of-care (POC) diagnostics is the latest trend being
observed in the microbiology testing market.
Geographically, the global microbiology
testing market is divided into five regions – North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North-America
holds the largest market share in terms of revenue followed by Europe.
Rising prevalence of various diseases among the population, refined
healthcare infrastructure, and rising need for advanced diagnostic
testing are the key reasons accounted for the market growth in North
America. Developing economies of Asia Pacific and Latin America such as
India, China, and Brazil are expected to experience a rapid expansion
due to favorable laws being incorporated in the country, tax benefits,
favorable reimbursement scenario, and increasing medical tourism in
these nations. Moreover, the rise in prevalence and severity of diseases
in emerging nations such as India, China, Indonesia, and Malaysia
propels the growth in the region.
Key players involved in the global
microbiology testing markets are Bio-Rad Laboratories, Becton Dickinson
and Company, Danaher, bioMérieux, and Thermo Fisher Scientific. Other
prominent vendors are Abbott Diagnostics, Alcon Laboratories, Cepheid,
Cavidi, and many more.
No comments:
Post a Comment